In summary, NCTD effectively inhibits the malignant proliferation of colon cancer cells by regulating the TRAF5/NF-κB signaling pathway and inducing programmed apoptosis, offering a novel treatment strategy. Here, NFKB1 is linked to malignant colon neoplasm.